Survivorship Research Award
Supports research improving quality of life and function for melanoma survivors, requiring survivor or advocate involvement, and allows clinical trials relevant to the Military Health System.
Funder: Military Health System Research Program
Due Dates (Anticipated): June 2026 (Letter of Intent) | September 2026 (Full Application)
Funding Amounts: Up to $1.015 million total costs over a maximum of 3 years per award.
Summary: Supports research to improve quality of life, function, and survivorship for melanoma patients, requiring survivor or advocate involvement and allowing clinical trials.
Key Information: Clinical trials are allowed; a melanoma survivor or patient advocate must be part of the research team.
Description
This opportunity supports innovative research focused on the survivorship of individuals diagnosed with melanoma. Projects should address the preservation of function, quality of life, symptom and treatment toxicity management, resilience, psychosocial support, and other survivorship-related aspects. The program requires that at least one melanoma survivor or patient advocate is an integral part of the research team to ensure research relevance and impact. Clinical trials are permitted. Applications must demonstrate relevance to the health care needs of Service Members, Veterans, and/or other beneficiaries of the Military Health System. Projects focusing exclusively on animal models or only on survival outcomes without addressing quality of life, health, or function are not eligible.
